Three privately-held biotech companies could be next in line for making the jump to public markets.

A little competition can greatly benefit patients. Shareholders may have a more difficult path to navigate.

Jim Cramer says stocks are caught between the forces of inflation and deflation, and investors need to find companies that can adapt.

Cathie Wood's Ark Investment bought shares of Germany’s Crispr Tuesday, a media report says. The stock slid on Wednesday.

'These data open a new era of medicine – one that holds the potential of curing genetic disease,' Intellia said. Its shares are higher.

Intellia Therapeutics rises and other gene-editing stocks follow suit.

Jim Cramer says on days like this, investors are going after what's new or exciting, searching for what he calls 'coolness-per-share.'

Intellia Therapeutics, QAD, Etsy, NRG Energy and Nvidia are five top stock gainers for Monday.

The genetics space has everyone's attention on Monday as traders look to capitalize on the potential of these stocks. Let's look at a few charts.

The S&P 500 Industrials index returned 3.99% over the past year, compared to a negative return for the S&P 500 overall.

Southwest Airlines has some major problems and passengers may be wary of flying the airline, but its current problems don't tell the whole story.

The two companies used social media to attract attention about their upcoming release, which shoe fans say could cost plenty.